Citigroup's earnings recovery is gaining traction, with diluted EPS rising from $4.04 in 2023 to an estimated $6.99 in 2025, supported by cost discipline and a strengthening institutional franchise. However, the stock already reflects much of this improvement, trading at a P/E of 13.6x—an 18% premium to its peer median—while recent insider selling at elevated prices suggests caution. The stock is a hold pending clearer evidence that the Asia wealth expansion and further buybacks can drive the next leg of re-rating without stalling on execution.
Macroeconomic downturn
A recession or credit cycle turn could raise loan loss provisions and pressure net interest income, reversing recent earnings gains.
Execution risk in Asia wealth push
The aggressive hiring of 500+ staff may not yield expected returns if client acquisition or market conditions disappoint.
Valuation compression
If EPS growth decelerates, the elevated P/E multiple could contract toward the peer median, limiting upside or causing price declines.
Regulatory headwinds
Changes in capital requirements or living-will reviews could raise costs or restrict capital return, despite the recent cleared review.